The role of FcRn in the pharmacokinetics of biologics in patients with multiple myeloma
SourceClinical Pharmacology and Therapeutics, 102, 6, (2017), pp. 903-904
Article / Letter to editor
Display more detailsDisplay less details
Clinical Pharmacology and Therapeutics
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.